Bicara Therapeutics Inc (NASDAQ:BCAX) shares, rose in value on Friday, May 30, with the stock price down by -2.01% to the previous day’s close as strong demand from buyers drove the stock to $9.25.
Actively observing the price movement in the last trading, the stock closed the session at $9.44. Referring to stock’s 52-week performance, its high was $28.09, and the low was $7.80. On the whole, BCAX has fluctuated by -35.63% over the past month.
With the market capitalization of Bicara Therapeutics Inc currently standing at about $504.46 million, investors are eagerly awaiting this quarter’s results, scheduled for in June.
The stock’s technical analysis shows that the price of BCAX currently trading nearly -28.00% and -27.65% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 35.54, while the 7-day volatility ratio is showing 5.39% which for the 30-day chart, stands at 13.13%. Furthermore, Bicara Therapeutics Inc (BCAX)’s average true range (ATR) is 1.66.
Data on historical trading for Bicara Therapeutics Inc (NASDAQ:BCAX) indicates that the trading volumes over the past 3 months, they’ve averaged 738.92K. According to company’s latest data on outstanding shares, there are 54.53 million shares outstanding.
Nearly 39.92% of Bicara Therapeutics Inc’s shares belong to company insiders and institutional investors own 62.30% of the company’s shares. The stock has fallen by -46.90% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the BCAX stock heading into the next quarter.
